vimarsana.com
Home
Live Updates
Chroma Medicine Highlights Data Demonstrating Durable Multiplex Epigenetic Editing to Enhance Allogeneic CAR T at 65th ASH Annual Meeting : vimarsana.com
Chroma Medicine Highlights Data Demonstrating Durable Multiplex Epigenetic Editing to Enhance Allogeneic CAR T at 65th ASH Annual Meeting
Chroma Medicine, Inc., (Chroma) a genomic medicine company pioneering single-dose epigenetic editing therapeutics, today presented data...
Related Keywords
Boston ,
Massachusetts ,
United States ,
San Diego ,
California ,
American ,
Vic Myer ,
Jamie Schafer ,
Prnewswire Chroma Medicine Inc ,
Twitter ,
Vivo Program Sciences ,
American Society Of Hematology ,
Linkedin ,
Enhance Allogeneic ,
American Society ,
Annual Meeting ,
Durable Multiplex Epigenetic Editing ,
Associate Director ,
vimarsana.com © 2020. All Rights Reserved.